Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
380 Leser
Artikel bewerten:
(2)

Sistema PJSFC: Binnopharm Group increases stake in Sintez to 88.6%

DJ Sistema PJSFC: Binnopharm Group increases stake in Sintez to 88.6%

Sistema PJSFC (SSA) 
Sistema PJSFC: Binnopharm Group increases stake in Sintez to 88.6% 
12-May-2021 / 10:00 MSK 
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 
(MAR), transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Binnopharm Group increases stake in Sintez to 88.6% 
12 May 2021, Moscow - Sistema PJSFC ("Sistema", the "Corporation" or, together with its subsidiaries and affiliates, 
the "Group") (LSE: SSA, MOEX: AFKS), a publicly traded Russian investment company, announces that its fully owned 
subsidiary LLC Sistema Telecom Assets has contributed its 32.4% stake in OJSC Sintez to the authorised capital of LLC 
Binnopharm Group. Following the transaction, Binnopharm Group has increased its stake in OJSC Sintez to 88.6%. 
As a result, the effective stake in Binnopharm Group owned by Sistema together with VTB, Sistema's financial partner in 
the development of the pharmaceuticals business, now stands at 86.5%. A consortium of investors consisting of the 
Russian Direct Investment Fund ("RDIF"), the Russia-China Investment Fund (co-founded by RDIF and China Investment 
Corporation) and leading Middle Eastern funds holds 12.5%, with the remaining 1% owned by a minority shareholder (an 
individual). 
Binnopharm Group is a full-cycle Russian pharmaceutical holding company that combines five production sites across 
Russia: JSC Alium (formerly OBL Pharm; Serpukhov district, Moscow region), JSC Binnopharm (two sites at Zelenograd and 
Krasnogorsk), JSC Sintez (Kurgan) and JSC Biocom (Stavropol). Binnopharm Group companies produce a wide range of drugs 
in various therapeutic groups and have the largest portfolio of drugs among Russian manufacturers with more than 450 
marketing authorisations, including the COVID-19 vaccine Sputnik V. 
*** 
For further information, please visit www.sistema.ru or contact: 
Press Service of Sistema IR Service 
Sergey Kopytov      Nikolai Minashin 
Phone: +7 (495) 228 15 32 Phone: +7 (495) 730 66 00 
kopytov@sistema.ru    n.minashin@sistema.ru 

Sistema PJSFC is a publicly traded Russian investment company with a diversified portfolio of assets serving over 150 million customers in the sectors of telecommunications, high technology, financial services, retail, paper and packaging, agriculture, real estate, tourism and medical services. The company was founded in 1993. Revenue in 2020 was RUB 691.6 billion; total assets equalled RUB 1.4 trillion as of 31 December 2020. Sistema's global depositary receipts are listed under the "SSA" ticker on the London Stock Exchange. Sistema's ordinary shares are listed under the "AFKS" ticker on the Moscow Exchange. Website: www.sistema.com. -----------------------------------------------------------------------------------------------------------------------

ISIN:     US48122U2042 
Category Code: MSCH 
TIDM:     SSA 
LEI Code:   213800JSZ2UUK4QQK694 
Sequence No.: 104444 
EQS News ID:  1195434 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1195434&application_name=news 
 

(END) Dow Jones Newswires

May 12, 2021 03:00 ET (07:00 GMT)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.